I think on the financials alone this could be a real bargain, for instance balance sheet now not much of an issue.
so....why no re-rate or any evidence of insto interest?
Ann: Quarterly Activities and Cashflow Reports, page-10
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.76M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 192311 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 173146 | 1 |
View Market Depth
| Last trade - 12.12pm 04/10/2024 (20 minute delay) ? |
| DNA (ASX) Chart |
Day chart unavailable